Chris Leather joins Sequence Bio as VP, Technology and Security

December 6, 2021

chris leather joins sequence bio as vp, technology and security

Newfoundland and Labrador-based biotechnology company Sequence Bio is pleased to announce that Chris Leather, Ph.D has joined its team as Vice President, Technology and Security. 

Leather joins Sequence Bio from the leadership team at Verafin, where he was responsible for supporting cloud services and security for some of the largest banks in North America. In five years as Director of Cloud and Security, he also played an important role in scaling the team and company to its $2.7 billion USD dollar acquisition by Nasdaq in 2021. 

With nearly 25 years of experience, Leather will lead Sequence Bio’s technology and application development teams, as well as the continual advancement of the security infrastructure that is essential to protecting the privacy of research participants and collaborating with global drug development partners. 

“Sequence Bio is quickly emerging as a global leader in drug discovery. Their vision, underpinned by a commitment to security and privacy excellence, made this an exciting opportunity for me. says Leather. “I look forward to working with the team to continue developing the leading-edge technology solutions that will support the company today and our growth well into the future.”

“Privacy and security is at the core of everything we do at Sequence Bio, and Chris was an essential part of building the technology behind the world’s top anti-financial crime management solutions,” says Chris Gardner, chief executive officer of Sequence Bio. “He is an industry expert with world-class credentials. We are very excited that he has joined our leadership team, and look forward to him playing a significant role in our continued growth and success.”

For additional information please contact

Chris McDonald
VP, Market Development
+1-800-296-3481 x708